Cargando…
Exclusion of patients living with HIV from cancer immune checkpoint inhibitor trials
Emerging retrospective and prospective studies indicate that immune checkpoint inhibitors (ICIs) can be safe and effective cancer treatments among people living with human immunodeficiency virus (PLWH), however this high-cancer-risk population has often been excluded from groundbreaking cancer ICI t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988004/ https://www.ncbi.nlm.nih.gov/pubmed/33758321 http://dx.doi.org/10.1038/s41598-021-86081-w |